Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02989857
Title Study of AG-120 in Previously Treated Advanced Cholangiocarcinoma With IDH1 Mutations (ClarIDHy)
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Agios Pharmaceuticals, Inc.
Indications

cholangiocarcinoma

Therapies

Ivosidenib

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP

Additional content available in CKB BOOST